Table 2.
Demographics and baseline characteristics of all patients
| Characteristic | Group 1 (n=35) | Group 2 (n=49) | Total (n=84) |
|---|---|---|---|
| Age (y) | |||
| ≥70 | 10 (29) | 13 (27) | 23 (27) |
| <70 | 25 (71) | 36 (73) | 61 (73) |
| Mean (SD) | 65.6 (8.0) | 65.4 (8.0) | 65.5 (8.0) |
| Median (range) | 66 (46-84) | 66 (43-78) | 66 (43-84) |
| Sex | |||
| Female | 9 (26) | 13 (27) | 22 (26) |
| Male | 26 (74) | 36 (73) | 62 (74) |
| WHO PS | |||
| 0 | 12 (34) | 20 (41) | 32 (38) |
| 1 | 23 (66) | 29 (59) | 52 (62) |
| Histology | |||
| Adenocarcinoma | 12 (34) | 14 (29) | 26 (31) |
| Squamous | 17 (49) | 30 (61) | 47 (56) |
| Other NSCLC | 6 (17) | 5 (10) | 11 (13) |
| Stage | |||
| IIA | 0 | 0 | 0 |
| IIB | 0 | 6 (12) | 6 (7) |
| IIIA | 24 (69) | 33 (67) | 57 (68) |
| IIIB | 11 (31) | 10 (20) | 21 (25) |
| GTV size (cm3) | |||
| Mean (SD) | 127.7 (118.9) | 118.0 (83.3) | 122.1 (99.4) |
| Median (range) | 110 (14-602) | 92 (15-329) | 109 (14-602) |
Abbreviations: GTV = gross tumor volume; NSCLC = non-small cell lung cancer; WHO PS = World Health Organization performance status.
Values are number (percentage) unless otherwise noted.